
KHTRF
Healthcare · Drug Manufacturers - Specialty & Generic · $831.4M market cap
$8.460.00 (0.0%)Nov 13, 3:42 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 6, 2026 | Before the open | 0.03 | -0.02 | -182.3% |
| May 7, 2026 | Before the open | 0.01 | 0.10 | +870.0% |
| Mar 19, 2026 | Before the open | 0.01 | 0.06 | +540.0% |
| Nov 6, 2025 | Before the open | 0.02 | -0.03 | -238.0% |
| Aug 7, 2025 | Time not confirmed | 0.02 | -0.09 | -557.5% |
| May 7, 2025 | Before the open | — | 0.02 | — |
| Mar 19, 2025 | Before the open | — | 0.08 | — |
| Nov 7, 2024 | Before the open | — | 0.00 | — |
| Aug 8, 2024 | Before the open | — | -0.01 | — |
| May 9, 2024 | Before the open | — | -0.03 | — |
| Mar 21, 2024 | Before the open | — | -0.18 | — |
| Nov 9, 2023 | Before the open | — | 0.07 | — |
| Aug 10, 2023 | Before the open | — | 0.01 | — |
Knight Therapeutics Inc. focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America. The company offers Minjuvi for relapsed or refractory diffuse large B-cell lymphoma; Pemazyre for metastatic cholangiocarcinoma; Akynzeo for prevention of chemotherapy-induced acute and delayed nausea and vomiting; Aloxi for prevention of acute…
| May 11, 2023 |
| Before the open |
| — |
| -0.03 |
| — |
| Mar 23, 2023 | Before the open | -0.08 | -0.13 | -62.5% |
| Nov 10, 2022 | Before the open | -0.04 | 0.01 | +125.0% |
| Aug 11, 2022 | Before the open | -0.02 | 0.02 | +200.0% |
| May 12, 2022 | Before the open | -0.04 | -0.16 | -300.0% |
| Mar 24, 2022 | Before the open | — | -0.07 | — |
| Nov 11, 2021 | Before the open | 0.02 | -0.07 | -450.0% |
| Aug 13, 2021 | Before the open | -0.07 | 0.23 | +428.6% |
| May 14, 2021 | Before the open | -0.02 | 0.03 | +250.0% |
| Mar 25, 2021 | Before the open | 0.01 | 0.06 | +500.0% |
| Nov 13, 2020 | Before the open | 0.00 | 0.14 | — |
| Aug 13, 2020 | Before the open | -0.02 | 0.13 | +750.0% |
| Jun 26, 2020 | Before the open | -0.06 | -0.01 | +83.3% |
| Mar 30, 2020 | After the close | 0.01 | -0.05 | -600.0% |
| Nov 12, 2019 | After the close | 0.03 | -0.02 | -166.7% |
| Aug 8, 2019 | Before the open | 0.02 | 0.13 | +550.0% |
| May 9, 2019 | Before the open | 0.03 | 0.04 | +33.3% |
| Mar 14, 2019 | Before the open | 0.03 | 0.03 | -9.3% |
| Nov 8, 2018 | Before the open | 0.02 | 0.09 | +350.0% |
| Aug 9, 2018 | Before the open | 0.03 | 0.03 | 0.0% |
| May 10, 2018 | Before the open | 0.04 | 0.05 | +25.0% |
| Mar 15, 2018 | Before the open | 0.04 | 0.05 | +25.0% |